The benefits and harms of breast cancer screening: An independent review

The Lancet

Volumn 380, Issue 9855, 2012, Pages 1778-1786

  Marmot, Michael ^a   Altman, D G ^b   Cameron, D A ^c   Dewar, J A ^d   Thompson, S G ^e   Wilcox, Maggie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION;

EID: 84869083222     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61611-0     Document Type: Review

References (32)

1. Forrest APM. Breast cancer screening: report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a working group. London: HM Stationery Office, 1987.
2. International Agency for Research on Cancer. IARC handbooks of cancer prevention (volume 7): breast cancer screening. Lyon: IARC, 2002.
3. Woolf SH. The 2009 Breast Cancer Screening Recommendations of the US Preventive Services Task Force. JAMA 2010; 303: 162-63.
4. Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011; 183: 1991-2001.
5. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011; 1: CD001877.
6. Cancer Research UK. Breast Screening Review. www.cruk.org.uk/ breastscreeningreview (accessed Oct 30, 2012).
7. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359: 909-19.
8. Tabar L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011; 260: 658-63.
9. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727-37, W237-42.
10. Duffy SW, Ming-Fang Yen A, Hsiu-Hsi Chen T, et al. Long-term benefits of breast screening. Breast Cancer Management 2012; 1: 31-38.
11. Schünemann H, Brozek J, Oxman A, eds. GRADE handbook for grading the quality of evidence and the strength of recommendations. The GRADE Working Group, 2009.
12. Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010; 17: 25-30.
13. Beral V, Alexander M, Duffy S, et al. The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. J Med Screen 2011; 18: 210-12.
14. Welch HG. How much overdiagnosis? 10 March 2006. http://www.bmj.com/ rapid-response/2011/10/31/how-much-overdiagnosis (accessed 14 Oct, 2012).
15. Puliti D, Duffy S, Miccinesi G, et al. The EUROSCREEN Working Group. Methodology and estimate of overdiagnosis in breast cancer service screening: a review of the European studies. J Med Screen 2012; 19 (suppl 1): 42-56.
16. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007; 8: 1129-38.
17. Puliti D, Miccinesi G, Paci E. Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med 2011; 53: 131-33.
18. de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011; 33: 111-21.
19. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of overdiagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006; 332: 689-92.
20. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-99.
21. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002; 137 (5 part 1): 305-12.
22. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977; 39: 2777-82.
23. Welch HG, Schwartz LM, Woloshin S. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ 2006; 332: 727.
24. Harris R, Yeatts J, Kinsinger L. Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. Prev Med 2011; 53: 108-14.
25. The Breast Screening Frequency Trial Group. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. Eur J Cancer 2002; 38: 1458-64.
26. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009; 339: b2587.
27. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011; 12: 21-29.
28. National Health Service Breast Screening Programme and Association of Breast Surgery. An audit of screen detected breast cancers for the year of screening April 2012 to March 2011. 2012. http://www.cancerscreening.nhs.uk/ breastscreen/publications/baso2010-2011.pdf (accessed Sept 13, 2012).
29. NHS Breast Screening Programme. Annual Review 2011. http://www. cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-annualreview2011.pdf (accessed Sept 13, 2012).
30. Bond M, Pavey T, Welch K, et al. Psychological consequences of false-positive screening mammograms in the UK. Evid Based Med 2012; published online Aug 2. DOI:10.1136/eb-2012-100608.
31. Fallowfield LJ, Hall A. Psychosocial and sexual impact of diagnosis and treatment of breast cancer. Br Med Bull 1991, 47: 388-99.
32. The Sloane Project. UK prospective audit of screen detected non-invasive carcinomas and atypical hyperplasias of the breast: Progress Report 2008/09 and 2009/10. http://www.sloaneproject.co.uk/documents/ Sloane%20Annual%20Report%202010%20web.pdf (accessed Oct 12, 2012).